日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care

INFINITY精准肿瘤学注册研究的最终结果:常规护理中晚期癌症患者的非标准靶向治疗

Sellmann, L; Marschner, D; Martens, U M; Schröder, J; Decker, T; Schuler, M; Schneeweiss, A; Reiser, M; Schuler, M K; Vannier, C; Looß, M; Woerner, S M; Grebhardt, S; Wright, P R; Dille, S; Kasenda, B; Busies, S; Potthoff, K

IDHIRA: a prospective, observational study on ivosidenib in patients with IDH1 R132-mutated advanced cholangiocarcinoma

IDHIRA:一项关于ivosidenib治疗IDH1 R132突变型晚期胆管癌患者的前瞻性观察研究

Michl, Marlies; Hagemeyer, Nora; Looß, Marion; Grebhardt, Sina; Ringwald, Kai; Potthoff, Karin

Deformation Behavior of 3D Printed Auxetic Structures of Thermoplastic Polymers: PLA, PBAT, and Blends

热塑性聚合物(PLA、PBAT及其共混物)3D打印拉胀结构的变形行为

Hufert, Jonas; Grebhardt, Axel; Schneider, Yanling; Bonten, Christian; Schmauder, Siegfried

Deformation Behavior Investigation of Auxetic Structure Made of Poly(butylene adipate-co-terephthalate) Biopolymers Using Finite Element Method

利用有限元法研究聚(己二酸丁二醇酯-对苯二甲酸丁二醇酯)生物聚合物制成的负泊松比结构的变形行为

Schneider, Yanling; Guski, Vinzenz; Schmauder, Siegfried; Kadkhodapour, Javad; Hufert, Jonas; Grebhardt, Axel; Bonten, Christian

The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice

INFINITY 研究方案:一项回顾性队列研究,旨在探讨生物标志物驱动的精准肿瘤学在常规临床实践中的决策制定和临床影响。

Martens, Uwe M; Schröder, Jan; Bengsch, Fee; Sellmann, Ludger; Busies, Sabine; Frank-Gleich, Stefanie; Zaiss, Matthias; Decker, Thomas; Schneeweiss, Andreas; Schuler, Martin; Grebhardt, Sina; Zacharias, Stefan; Marschner, Norbert; Kasenda, Benjamin; Potthoff, Karin; Vannier, Corinne

Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials

泊马度胺联合地塞米松治疗复发或难治性多发性骨髓瘤患者:非干预性研究 POSEIDON 的最终结果及与关键性 3 期临床试验的比较

Dechow, Tobias; Aldaoud, Ali; Behlendorf, Timo; Knauf, Wolfgang; Eschenburg, Henning; Groschek, Matthias; Hansen, Richard; Söling, Ulrike; Grebhardt, Sina; Siebenbach, Hans Ulrich; Vannier, Corinne; Potthoff, Karin

Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients

患者、护士和医生的偏好:CONVENIENCE 研究的最终结果,该研究评估了通过预充式注射器或体外注射器在癌症患者中使用培非格司亭进行预防性治疗的效果。

Metz, Michael; Semsek, Dieter; Rogmans, Gunther; Hutzschenreuter, Ulrich; Fietz, Thomas; Harde, Johanna; Zacharias, Stefan; Hielscher, Carsten; Lorenz, Andreas; Zahn, Mark-Oliver; Guth, Dagmar; Liebers, Steffen; Berghorn, Michael; Grebhardt, Sina; Matillon, Christiane D; Egerer, Gerlinde; Potthoff, Karin

Additive Manufacturing of β-Tricalcium Phosphate Components via Fused Deposition of Ceramics (FDC)

通过熔融沉积陶瓷(FDC)增材制造β-磷酸三钙部件

Esslinger, Steffen; Grebhardt, Axel; Jaeger, Jonas; Kern, Frank; Killinger, Andreas; Bonten, Christian; Gadow, Rainer